Soluble ICAM‐1 a Pivotal Communicator between Tumors and Macrophages, Promotes Mesenchymal Shift of Glioblastoma

Despite aggressive clinical treatment, recurrence of glioblastoma multiforme (GBM) is unavoidable, and the clinical outcome is still poor. A convincing explanation is the phenotypic transition of GBM cells upon aggressive treatment such as radiotherapy. However, the microenvironmental factors contri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Ki‐Chun, Kang, Jae‐Hyeok, Choi, Mi‐Young, Suh, Yongjoon, Zhao, Yi, Kim, Min‐Jung, Chang, Jong Hee, Shim, Jin‐Kyoung, Yoon, Seon‐Jin, Kang, Seok‐Gu, Lee, Su‐Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805565/
https://www.ncbi.nlm.nih.gov/pubmed/34813169
http://dx.doi.org/10.1002/advs.202102768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805565/
https://www.ncbi.nlm.nih.gov/pubmed/34813169
http://dx.doi.org/10.1002/advs.202102768

Ejemplares similares